David Claveau
Impact in
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- Antimicrobial Resistance in Staphylococcus
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- Inflammatory mediators and NSAID effects 9
-
- Antimicrobial Resistance in Staphylococcus 3
- Co-authors
- Joseph A. Mancini (8 shared papers)Denis Riendeau (10 shared papers)Jocelyne Guay (6 shared papers)Robert J. Gordon (6 shared papers)Chi‐Chung Chan (4 shared papers)M. David Percival (1 shared paper)Chun Li (1 shared paper)Mirna Sirinyan (1 shared paper)
- Journals
- Bioorganic & Medicinal Chemistry Letters (9 papers)Biochemical Pharmacology (3 papers)Journal of Cellular Physiology (2 papers)Science Translational Medicine (1 paper)Journal of Emergency Medicine (1 paper)
- Partner nations
- CanadaUnited StatesPortugal
In The Last Decade
David Claveau
38 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 109
- Pharmacology 502
- Infectious Diseases 290
- Organic Chemistry 273
- Molecular Medicine 53
- Computational Theory and Mathematics 125
Countries citing papers authored by David Claveau
This map shows the geographic impact of David Claveau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Claveau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Claveau more than expected).
Fields of papers citing papers by David Claveau
This network shows the impact of papers produced by David Claveau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Claveau. The network helps show where David Claveau may publish in the future.
Co-authors
The 25 scholars most cited alongside David Claveau, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 222 | |
| 2 | 2001 | 213 | |
| 3 | 2021 | 203 | |
| 4 | 2003 | 169 | |
| 5 | 2007 | 118 | |
| 6 | 1999 | 113 | |
| 7 | 2004 | 89 | |
| 8 | 2003 | 70 | |
| 9 | 2012 | 68 | |
| 10 | 2009 | 57 | |
| 11 | 2007 | 53 | |
| 12 | 1999 | 49 | |
| 13 | 2011 | 48 | |
| 14 | 2012 | 32 | |
| 15 | 1997 | 29 | |
| 16 | 2005 | 27 | |
| 17 | 1999 | 24 | |
| 18 | 2002 | 24 | |
| 19 | 2007 | 23 | |
| 20 | 2011 | 22 |
About David Claveau
David Claveau is a scholar working on Pharmacology, Infectious Diseases, Molecular Biology, Cancer Research and Organic Chemistry, having authored 38 papers that have together received 1.8k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (9 papers), Phosphodiesterase function and regulation (6 papers), Ion Transport and Channel Regulation (5 papers), Protease and Inhibitor Mechanisms (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers), Synthesis and biological activity (3 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Streptococcal Infections and Treatments (1 paper). The work is most often cited by research in Pharmacology (502 citations), Infectious Diseases (290 citations), Organic Chemistry (273 citations), Molecular Medicine (53 citations) and Computational Theory and Mathematics (125 citations). David Claveau has collaborated with scholars based in Canada, United States and Portugal. Frequent co-authors include Joseph A. Mancini, Denis Riendeau, Jocelyne Guay, Robert J. Gordon, Chi‐Chung Chan, M. David Percival, Chun Li, Mirna Sirinyan, Christine Brideau and Marie Leclerc. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Biochemical Pharmacology, Journal of Cellular Physiology, Science Translational Medicine and Journal of Emergency Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.